United States · FDA National Drug Code directory
Arformoterol Tartrate Inhalation
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73043-052_8f1bd281-a307-4e2c-8796-6b55495bd3e2
- Product NDC
- 73043-052
- Form
- SOLUTION
- Composition / generic term
- Arformoterol Tartrate Inhalation
- Labeler
- Devatis, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250801
- Source listing expiry
- 20261231
Source-listed ingredients
- ARFORMOTEROL TARTRATE — 15 ug/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 60 POUCH in 1 CARTON (73043-052-60) / 4 VIAL in 1 POUCH (73043-052-04) / 2 mL in 1 VIAL · 73043-052-60
- 30 POUCH in 1 CARTON (73043-052-93) / 1 VIAL in 1 POUCH (73043-052-01) / 2 mL in 1 VIAL · 73043-052-93
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →